In Vitro and In Vivo Gene Transfer by an Optimized α-Cyclodextrin Conjugate with Polyamidoamine Dendrimer
- 12 February 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 14 (2) , 342-350
- https://doi.org/10.1021/bc025613a
Abstract
The purpose of the present study is to optimize the structure of the polyamidoamine starburst dendrimer (dendrimer) conjugate with α-cyclodextrin (α-CDE conjugate) as a nonviral vector. α-CDE conjugates of dendrimer (generation 3, G3) with various average degrees of substitution (DS) of α-CyD of 1.1, 2.4, and 5.4 were prepared. α-CDE conjugates formed the complexes with pDNA, resulting in a change of the particle sizes of pDNA complexes, but the distinction of physicochemical properties among their vector/pDNA complexes was only very slight. The membrane-disruptive ability of α-CDE conjugates on liposomes encapsulating calcein and their cytotoxicity to NIH3T3 and HepG2 increased with an increase in the DS value of α-CyD. In vitro gene transfer activity of α-CDE conjugates in both NIH3T3 and HepG2 cells augmented as the charge ratio (vector/pDNA) increased, and the activity of α-CDE conjugate (DS 2.4) was the highest at higher charge ratios among dendrimer (G3), the three α-CDE conjugates, and TransFast. After intravenous administration of pDNA complexes in mice, α-CDE conjugate (DS 2.4) delivered pDNA more efficiently in spleen, liver, and kidney, compared with dendrimer and other α-CDE conjugates (DS 1.1 and 5.4). The potential use of α-CDE conjugate (G3, DS 2.4) could be expected as a nonviral vector in vitro and in vivo, and these data may be useful for design of α-CyD conjugates with other nonviral vectors.Keywords
This publication has 14 references indexed in Scilit:
- Design and gene delivery activity of modified polyethyleniminesPublished by Elsevier ,2001
- Cyclodextrins in oligonucleotide deliveryAdvanced Drug Delivery Reviews, 2001
- Gene Therapy: Promises and ProblemsAnnual Review of Genomics and Human Genetics, 2001
- Key issues in non-viral gene delivery1PII of original article: S0169-409X(98)00048-9. The article was originally published in Advanced Drug Delivery Reviews 34 (1998) 3–19.1Advanced Drug Delivery Reviews, 2001
- Cyclodextrins in peptide and protein deliveryAdvanced Drug Delivery Reviews, 1999
- Proteoglycans Mediate Cationic Liposome-DNA Complex-based Gene Delivery in Vitro and in VivoJournal of Biological Chemistry, 1998
- Efficacy, Safety and Mechanism of Cyclodextrins as Absorption Enhancers in Nasal Delivery of Peptide and Protein DrugsJournal of Drug Targeting, 1998
- Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety EvaluationJournal of Pharmaceutical Sciences, 1997
- Cyclodextrin Derivatives in PharmaceuticsCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- Synthesis of monosubstituted cyclohexaamylosesCarbohydrate Research, 1971